
    
      The study consists of dose escalation and dose expansion. The preset dose of Donafenib is 50
      mg BID, 100 mg BID and 200 mg BID, and the preset dose of KN046 is 5 mg/kg Q3W. Dose
      expansion will enroll subjects who with advanced hepatocellular carcinoma.
    
  